Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines

Open Med. 2014 Oct 14;8(4):e130-5. eCollection 2014.

Authors

Reed F Beall¹, Jason W Nickerson², Amir Attaran³

Affiliations

¹ Reed F. Beall, MA, is a PhD candidate in the Institute of Population Health at the University of Ottawa, Ottawa, Ontario.
² Jason W. Nickerson, RRT, PhD, is a Clinical Investigator at the Bruyère Research Institute, Ottawa, Ontario.
³ Amir Attaran, DPhil, LLB, is Associate Professor and Canada Research Chair in Law, Population Health and Global Development Policy at the University of Ottawa, Ottawa, Ontario.

PMID: 25426181
PMCID: PMC4242790

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Canada
Cost Control
Costs and Cost Analysis / statistics & numerical data*
Drugs, Generic / economics*
Global Health
Humans

Substances

Drugs, Generic

Grants and funding

Canadian Institutes of Health Research/Canada